Endocrine System Diseases Clinical Trial
Official title:
Effect of Amino Acids and Sugar Alcohols on Gastric Emptying and Release of Satiation Peptides in Normal Weight and Obese Subjects
NCT number | NCT02563847 |
Other study ID # | EKBB 2014/072 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | May 26, 2015 |
Last updated | September 28, 2015 |
Start date | May 2014 |
Verified date | September 2015 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Ethikkommission |
Study type | Interventional |
With this study the investigators investigate the effects of amino acids (tryptophan in two different concentrations, leucin) and sugar alcohols (xylitol, erythritol) on satiety mechanisms.
Status | Completed |
Enrollment | 20 |
Est. completion date | |
Est. primary completion date | March 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Healthy normal weight subjects with a body-mass index of 19.0-24.9 - Healthy obese subjects with a body-mass index of > 30 - Normal eating habits (no diets; no dietary changes; no special dietary habits, such as vegetarian/vegan) - Age 18-40 years - Stable body weight for at least three months Exclusion Criteria: - Smoking - Substance abuse - Regular intake of medications (except for oral contraceptives) - Medical or psychiatric illness - History of gastrointestinal disorders - Food allergies - Pregnancy, breast feeding |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Basel, Phase 1 Research Unit | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effect of different aminoacids and sugar alcohols on secretion of satiation hormones | Plasma concentrations of glucose | changes from baseline to three hours after treatment | No |
Primary | Effect of different aminoacids and sugar alcohols on secretion of satiation hormones | Plasma concentrations of insulin are measured | changes from baseline to three hours after treatment | No |
Primary | Effect of different aminoacids and sugar alcohols on secretion of satiation hormones | Plasma concentrations of glucagon are measured | changes from baseline to three hours after treatment | No |
Primary | Effect of different aminoacids and sugar alcohols on secretion of satiation hormones | Plasma concentrations of glucagon-like Peptide (GLP-1) are measured | changes from baseline to three hours after treatment | No |
Primary | Effect of different aminoacids and sugar alcohols on secretion of satiation hormones | Plasma concentrations of PYY are measured | changes from baseline to three hours after treatment | No |
Primary | Effect of different aminoacids and sugar alcohols on secretion of satiation hormones | Plasma concentrations of cholecystokinin are measured | changes from baseline to three hours after treatment | No |
Secondary | Effect of different aminoacids and sugar alcohols on gastric emptying | measured by C13 breath test | changes from baseline to four hours after treatment | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A | |
Active, not recruiting |
NCT05505994 -
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
|
Phase 3 | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Recruiting |
NCT03682640 -
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes
|
Phase 2 | |
Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
Terminated |
NCT00174187 -
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
|
Phase 3 | |
Completed |
NCT03717298 -
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
|
Phase 2 | |
Active, not recruiting |
NCT05014204 -
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
|
N/A | |
Completed |
NCT03562897 -
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
|
Phase 2 | |
Completed |
NCT01727973 -
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
|
Phase 1/Phase 2 | |
Recruiting |
NCT06112340 -
A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05445284 -
Group Education Trial to Improve Transition for Parents of Adolescents With T1D
|
N/A | |
Terminated |
NCT04371978 -
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
|
Phase 3 | |
Completed |
NCT03725813 -
Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit
|
N/A | |
Recruiting |
NCT04556071 -
Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer
|
Phase 2 | |
Terminated |
NCT03335254 -
A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
|
Phase 1/Phase 2 | |
Completed |
NCT04488432 -
Endocrine, Bone And Metabolic Disorders In Adults After Allogeneic Stem-cell Transplant
|
||
Recruiting |
NCT05084079 -
Different Initial Insulin Dose Regimens on Time to Achieve Glycemic Targets and Treatment Safety in SIIT
|
Phase 4 | |
Completed |
NCT03305016 -
A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
|
Phase 3 |